Conno Christou is one of the most health-tracked founders you’ll meet. He wears a Whoop, cross-checks it against an Oura ring, and runs nearly 100 biomarkers every year. Then, as TechCrunch AI reports, the 35-year-old was diagnosed with an aggressive non-Hodgkin’s lymphoma that no wearable predicted, a rare cancer hitting roughly one in 420,000 people. What stands out is what he did next: he ran his treatment like a data problem and used Claude to ask sharper questions than the system handed him.
This is significant because a third of American adults now use chatbots for health information, according to a March poll cited by TechCrunch AI. Here’s how Christou actually did it, step by step, plus the cautions experts attach to it.
Quick Start: You’ll learn how one patient used AI as a research partner during a cancer diagnosis. What you need: your own medical records (bloodwork, scans, journals), access to a capable AI model, and the discipline to verify everything with real doctors. AI here is a question-sharpener, not a doctor.
📋 The Playbook
- Track your baseline data. Christou had four straight years of annual bloodwork and wearable history. Why it matters: when something goes wrong, you already have a personal baseline to compare against, not a blank chart.
- Don’t accept the first recommendation. His first oncologist suggested the lighter chemo regimen. The night before his first infusion, he sought a second opinion. That doctor recommended the harder regimen, pushing his odds from roughly 60% to around 85%. “As founders, we hold the wheel,” Christou says. “You don’t have to follow the first advice.”
- Gather many opinions, not two. Over two days he collected 12 opinions total, calling hematologists and oncologists in the US and abroad. The vote came back 11 to 1 for the harder path. He took it. Why it matters: one expert can be wrong; a weighted consensus is harder to argue with.
- Log everything as data. He kept a symptom journal using voice transcription, recording every side effect, medication, and counter-medication. His Whoop flagged the days his immune system would bottom out, sometimes before symptoms showed. Why it matters: structured records turn a chaotic experience into something an AI can actually analyze.
- Narrow your focus. He tracked three variables: sleep, nutrition, and, above all, psychology. “It moves the needle more than anything,” he said. “I never asked ‘why me,’ not once. That question has no useful answer.”
- Feed it all into the model to ask better questions. He fed blood results, scan data, wearable output, and journal entries into Claude. His framing is the key lesson: “It didn’t replace the doctors,” he says, but it “helped me ask the right questions.” For a cancer an oncologist might see once a year, a model trained on the full medical literature beat a Google search.
- Use AI to pressure-test ambiguous results. His final PET scan came back unclear, and his oncologist raised radiotherapy near his heart and lungs. Christou learned the false-positive rate on these scans runs around 60%. He fed three PET scans and an MRI into Claude, which flagged thymus rebound, a known phenomenon in patients under 40 where the gland reactivates after chemo and mimics active disease. The model put it at roughly 90%.
- Verify with humans before acting. He sought three more opinions. The fourth doctor confirmed thymus rebound. No active disease. No radiotherapy needed.
⚠️ The Caution: Experts are not sold on chatbots for diagnosis. Danielle Bitterman, clinical lead for data science and AI at Mass General Brigham, told the New York Times that general-purpose chatbots are frequently wrong and “have not been thoroughly evaluated” for personalized diagnoses. Christou agrees. The model informed his questions; doctors made the calls.
Next steps: Start a structured health journal now, before you need one. Keep copies of your own scans and labs. And if you ever face a major diagnosis, treat AI as a second researcher who helps you interrogate the experts, never as the final word. More details are in the original TechCrunch AI report.